Nucrest Pharma Private Limited, a active private limited company, was established on 09 December 2019 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24110MH2019PTC334133. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
Its leadership includes Ashok Rupchand Panjwani (Director), Vikram Ashok Panjwani (Director). It holds ₹7.80 Cr open charges and ₹6.33 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Office No.2307 & 2308 Parinee L Shah, Industrialestateoffveeradesairoad,, Mumbai, Maharashtra, 400053.
U24110MH2019PTC334133
334133
09 December 2019
₹1.00 Cr
₹1.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Nucrest Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashok Rupchand Panjwani | Director | 09 Dec 2019 | Current |
| Vikram Ashok Panjwani | Director | 09 Dec 2019 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nucrest Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 40.64% decrease. The company also saw a substantial fall in profitability, with a 23.81% decrease in profit. The company's net worth Soared by an impressive increase of 56.88%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Nucrest Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹78,010,000.00
₹63,296,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jul 2025 | Others | ₹5.00 Cr | Open |
| 17 Aug 2023 | Others | ₹1.56 M | Open |
| 31 Dec 2020 | Others | ₹2.65 Cr | Open |
| 21 Mar 2025 | Others | ₹7.20 M | Satisfied |
| 12 Mar 2025 | Others | ₹2.25 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Nucrest Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nucrest Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nucrest Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Nucrest Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on A charge registered on 21 Mar 2025 via Charge ID 101076002 with Others was fully satisfied on 11 Aug 2025. was documented.
Progress on A charge registered on 12 Mar 2025 via Charge ID 101070900 with Others was fully satisfied on 11 Aug 2025. was documented.
The activity A charge registered on 06 Mar 2025 via Charge ID 101070907 with Others was fully satisfied on 11 Aug 2025. was completed.
A charge registered on 05 Mar 2025 via Charge ID 101070909 with Others was fully satisfied on 11 Aug 2025. was recorded as a recent event.
A charge registered on 11 Mar 2025 via Charge ID 101070334 with Others was fully satisfied on 05 Aug 2025. was recorded as a recent event.
The CIN of Nucrest Pharma Private Limited is U24110MH2019PTC334133.
Nucrest Pharma Private Limited is headquartered at Office No.2307 & 2308 Parinee L Shah, Industrialestateoffveeradesairoad,, Mumbai, Maharashtra, 400053.
Nucrest Pharma Private Limited was incorporated on 09 December 2019.
The current directors of Nucrest Pharma Private Limited are
The primary industry of Nucrest Pharma Private Limited is Trade.
Nucrest Pharma Private Limited is unlisted.
The authorized capital of Nucrest Pharma Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX